Enter your terms above and click the 'Search' button.

Showing articles 0 to 15 of 15 Filter Applied: immunomodulation (Click to remove) Neurological Immune-Related Adverse Events of Ipilimumab Pract Neurol 13:278-280, Bot, I.,et al, 2013 Monoclonal Antibody Therapies and Neurologic Disorders Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008 Management of Possible Multiple Sclerosis NEJM 388:2195-2190, , 2023 Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement Neurol 90:e90-e93, Lovett, A.,et al, 2018 Recurrent Dysarthria and Ataxia in a Young Girl JAMA Neurol 75:125-126, Romba, M.,et al, 2018 A 77-year-old man presenting with episodic expressive aphasia Neurol 90:e1822-e1826, Shanklin, A.,et al, 2018 Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy Neurol 91:e359-e363, Rauer,S.,et al, 2018 Morvan Syndrome as a Paraneoplastic Disorder of Thymoma with Anti-CASPR2 antibodies Lancet 389:1367-1368, Vale, T.C.,et al, 2017 An 82-year-old man with Worsening Gait Neurol 89:e246-e252, Chew, S.,et al, 2017 Inflammatory Muscle Diseases NEJM 372:1734-1747, Dalakas, M.C., 2015 Varicella-Zoster Virus Encephalitis and Vasculopathy in a Patient Treated with Fingolimod Neurol 79:2002-2004,1942, Ratchford, J.,et al, 2012 Optic Neuritis: Prognosis and Treatment UpToDate, Jan, Osborne, B.,et al, 2011 Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients Medicine 89:166-175, Mu�oz,P., et al, 2010 Evaluation and Treatment of Inflammatory Myopathies JNNP 80:1060-1068, Amato,A. &Barohn,R.J., 2009 Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008 Showing articles 0 to 15 of 15